# Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

> **NCT07196839** · — · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Transthyretin (TTR) Amyloid Cardiomyopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07196839
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-31
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07196839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07196839, "Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT07196839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*